Skip to Content

Xerox Earnings: Mixed Quarter as Weak Sales Are Offset by Improving Profitability

Technology Sector artwork

We maintain our $13 fair value estimate for no-moat Xerox XRX after the firm reported a mixed third quarter, with weaker-than-expected sales offset by improved profitability. We continue to have a weak outlook on Xerox’s long-term opportunity in a print landscape marred by secular decline. While we commend Xerox’s laser focus on profitability and operational efficiency, we’d like to see a similar level of attention given to a top line that continues to trend downward. With shares down more than 7% following the company’s earnings release, we view Xerox as fairly valued.

Third-quarter sales clocked in at $1.65 billion, down 6% both sequentially and year over year. Equipment sales, a bright spot in the last couple of quarters, struggled in the third quarter, declining 1% year over year and 8% sequentially to $386 million. Post-sale revenue, which constitutes more than 75% of Xerox’s top line, declined 7% year over year as Xerox’s customers bought less paper and IT endpoint devices. From a macroeconomic standpoint, Xerox continued to see softness in demand as customers dial back spending in the current uncertain macro environment.

On the margin front, a mix of pricing actions and ongoing cost-cutting measures enabled Xerox to increase adjusted operating margins to 4.1%, up 40 basis points year over year. As aforementioned, we commend Xerox’s focus on profitability, with the firm generating more than $100 million in free cash flow in the third quarter.

Looking ahead, Xerox maintained its adjusted operating margin outlook for the year of 5.75%, factoring in benefits from the continued cost optimization the firm is undergoing. The emphasis on operational efficiency should also help the firm’s cash generation, with Xerox targeting at least $600 million in free cash flow for 2023. Xerox maintained its guidance for sales, with 2023 sales projected to be flat to down single digits in constant currency terms.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.

More in Stocks

About the Author

Sponsor Center